Celularity (CELU) Capital Expenditures (2020 - 2024)

Celularity (CELU) has reported Capital Expenditures for 5 consecutive years, with $1.4 million the latest figure, recorded in Q4 2024.

• On a quarterly basis, Capital Expenditures rose 383.11% year-over-year to $1.4 million in Q4 2024; TTM through Dec 2024 was $1.5 million, a 43.13% increase from a year earlier, with the FY2024 full-year figure at $1.5 million, up 43.13% from the prior year.
• Capital Expenditures was $1.4 million for Q4 2024 at Celularity, up from $31000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $9.4 million in Q4 2020 and troughed at -$258000.0 in Q3 2023.
• A 5-year average of $1.5 million and a median of $1.2 million in 2021 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures plunged 116.51% in 2023 and jumped 383.11% in 2024, its largest moves.
• Over 5 years, Capital Expenditures stood at $9.4 million in 2020, then sank by 75.43% to $2.3 million in 2021, then slumped by 66.17% to $779000.0 in 2022, then sank by 62.0% to $296000.0 in 2023, then surged by 383.11% to $1.4 million in 2024.
• The last three Capital Expenditures figures came in at $1.4 million (Q4 2024), $31000.0 (Q2 2024), and $39000.0 (Q1 2024), per Business Quant data.